3654 results for «209»

Filter By

3654 results

When complications storm through the cathlab: part 2

07 Dec 2023 – From GulfPCR-GIM 2023

The continuation of this session focuses on complications that may occur during PCI in the cathlab. Through the lens of these cases, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.

Stuck between a rock and a hard place: when calcium is the enemy!

07 Dec 2023 – From GulfPCR-GIM 2023

Have you ever wondered what tools and techniques to use when faced with calcified lesions? Watch this session to discover various cases of severely calcified lesions: the use of IVUS guidance and rota-cut when faced with tough calcium, PCI of a stubborn fibrotic coronary lesion, as...

Challenging CTO interventions: part 3

07 Dec 2023 – From GulfPCR-GIM 2023

In this session, broaden your knowledge in CTO treatment by exploring these diverse cases: delve into the complexities of managing double CTO lesions with ACS, gain insights into the ambiguous ostium antegrade CTO, and explore effective techniques such as the semi stent crush technique for closing...

Challenging structural interventions: part 2

07 Dec 2023 – From GulfPCR-GIM 2023

In this session, discover challenging structural interventions cases, such as the treatment of a large perm catheter related right atrial massa, transcatheter tricuspid valve-in-valve, post-TAVI severe hypotension, and more!

Challenging STEMI scenarios: part 2

07 Dec 2023 – From GulfPCR-GIM 2023

In this session, delve into intricate STEMI cases, featuring presentations on the challenges of primary PCI for left main, the significance of IVUS in STEMI patients during primary PCI, a compelling exploration of myocardial infarction in an anomalous coronary artery, and much more!

Tailored approaches to complex bifurcation PCI: part 2

07 Dec 2023 – From GulfPCR-GIM 2023

Consult this session to discover various complex PCI bifurcation cases, and learn more about the step by step approach on how to treat an ostial LAD lesion, and relevant procedures, such as the cutting balloon angioplasty, CABG or the trifurctional intervention.

Complex left main PCI: ancillary tools for safer interventions

07 Dec 2023 – From GulfPCR-GIM 2023

Consult this session to discover complex left main PCI cases, such as a severe stenosis in the distal left main bifurcation and differentiating atherosclerotic lesions from catheter-induced vasospasm, explore effective techniques such as imaging-guided optimisation for complex angioplasty, and more!

When complications storm through the cathlab: part 3

07 Dec 2023 – From GulfPCR-GIM 2023

These slides focus on complications that may occur during PCI in the cathlab. Through the lens of this case, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent
Didn’t find what you were looking for?